MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
This study has public registry information. It focuses on schizophrenia and currently lists study information in Canada and the United States.
Schizophrenia, Dementia, ...DrugOver 50 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether MP-101 may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive MP-101, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Canada and in the United States.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Canada · 3 sites
SKDS Research Inc.
Newmarket, Ontario
Site status: Not listed — confirm with the team
Montreal Neurological Institute
Montreal, Quebec
Site status: Not listed — confirm with the team
Centre de recherche sur le vieillissement du CIUSSS de l'Estrie - CHUS
Sherbrooke, Quebec
Site status: Not listed — confirm with the team
United States · 17 sites
Dignity Health (St. Joseph Hospital and Medical Center)
Phoenix, Arizona
Site status: Not listed — confirm with the team
Neuro-Therapeutics Inc
Pasadena, California
Site status: Not listed — confirm with the team
Associated Neurologists of Southern CT
Fairfield, Connecticut
Site status: Not listed — confirm with the team
Marcus Neuroscience Institute
Boca Raton, Florida
Site status: Not listed — confirm with the team
Meridien Research
Brooksville, Florida
Site status: Not listed — confirm with the team
Galiz Research
Hialeah, Florida
Site status: Not listed — confirm with the team
Galiz Research
Miami Springs, Florida
Site status: Not listed — confirm with the team
CNS
Orlando, Florida
Site status: Not listed — confirm with the team
Parkinson's Disease Treatment Center of SW Florida
Port Charlotte, Florida
Site status: Not listed — confirm with the team
Meridien Research Inc
St. Petersburg, Florida
Site status: Not listed — confirm with the team
University of South Florida
Tampa, Florida
Site status: Not listed — confirm with the team
College Park Family Care Neuro
Overland Park, Kansas
Site status: Not listed — confirm with the team
J. Gary Booker, MD, Clinical Trials
Shreveport, Louisiana
Site status: Not listed — confirm with the team
Alzheimer's Research Corporation
Paterson, New Jersey
Site status: Not listed — confirm with the team
Clarity Clinical Research
East Syracuse, New York
Site status: Not listed — confirm with the team
Richmond Behavioral Associates
Staten Island, New York
Site status: Not listed — confirm with the team
Neurology Diagnostics Inc
Dayton, Ohio
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT03044249. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving MP-101, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with schizophrenia; age range: Over 50 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Mediti Pharma Inc., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
